-
Mashup Score: 1Prevalence and predictors of sexual dysfunction in females with type 1 diabetes: a systematic review and meta-analysis - 7 month(s) ago
AbstractBackground. Several observational studies have explored the prevalence and predictors of female sexual dysfunction (FSD) among females with type 1 diabe
Source: academic.oup.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t sign in? Forgot your username? Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins School of Medicine, Baltimore, Maryland Department of Epidemiolog
Source: www.acpjournals.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 1Semaglutide Could Eliminate Need for Insulin in Type 1 Diabetes - 8 month(s) ago
A case series of 10 patients with newly diagnosed type 1 diabetes provides insight into the beneficial effects of off-label semaglutide use on insulin use, HbA1c, and fasting C-peptide levels among this patient population.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
These findings highlight the association between enteroviruses and islet autoimmunity or type 1 diabetes. Our data strengthen the rationale for vaccine development targeting diabetogenic enterovirus types, particularly those within Enterovirus B. Prospective studies of early life are needed to elucidate the role of enterovirus timing, type, and infection duration on the initiation of islet autoimmunity and the progression to type 1 diabetes.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0T1D Screening Options - 9 month(s) ago
Linda A. DiMeglio, MD, reviews screening options for patients with a family history of T1D, highlighting TrialNet.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
An analysis of real-world data provides an overview of the effects of GLP-1 receptor agonist and SGLT2 inhibitor use among adults with type 1 diabetes.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Prolonged clinical remission of type 1 diabetes sustained by calcifediol and low-dose basal insulin: a case report | Immunotherapy - 10 month(s) ago
Herein, we describe an unusually prolonged duration (31 months) of the clinical remission phase in a 22-year-old Italian man with new-onset type 1 diabetes. Shortly after the disease diagnosis, the patient was treated with calcifediol (also known as 25-hydroxyvitamin D3 or calcidiol), coupled with low-dose basal insulin, to correct hypovitaminosis D and to exploit the anti-inflammatory and immunomodulatory properties of vitamin D. During the follow-up period, the patient retained a substantial residual β-cell function and remained within the clinical remission phase, as evidenced by an insulin dose-adjusted glycated hemoglobin value <9. At 24 months, we detected a peculiar immunoregulatory profile of peripheral blood cells, which may explain the prolonged duration of the clinical remission sustained by calcifediol as add-on treatment to insulin.
Source: www.futuremedicine.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Minute Insight: Dexcom Next-Generation G7 CGM Approved In Canada - 10 month(s) ago
Dexcom wins Health Canada approval to market its G7 CGM in Canada, following announcements of its ambitious R&D map to expand into metabolic health and new product plans for consumers and the diabetes markets at ADA.
Source: Medtech InsightCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Pediatric Diabetes, DKA Rates Increased During Early COVID-19 Pandemic - 10 month(s) ago
Type 1 diabetes incidence was 1.14 times higher in the first year and 1.27 times higher in the second year of the COVID-19 pandemic, compared with the 12 months before the pandemic.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 1Intervention combining education, emotional focus best for reducing diabetes distress - 11 month(s) ago
SAN DIEGO — Adults with type 1 diabetes may reduce diabetes distress through multiple types of interventions, with the greatest distress reductions observed in programs combining education with an emotional focus on diabetes.In findings from the EMBARK trial presented at the American Diabetes Association Scientific Sessions, researchers analyzed data from adults with type 1 diabetes and
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet
Study finds prevalence of female sexual dysfunction (FSD) risk is 3.77x higher in type 1 diabetes patients. Predictors include depression and longer diabetes duration. Clinicians should prioritize FSD in diabetes care: https://t.co/N77ozipYnl #Type1Diabetes #SexualHealth https://t.co/Bic0UTa60i